Uniting tofight skin cancerand save lives
We are a community of over 1,500 professionals dedicated to reducing the incidence and impact of skin cancer in New Zealand
2026 New Zealand Skin Cancer Summit
18 - 20 June 2026 | InterContinental Wellington
Leading the fight against skin cancer
Skin Cancer NZ is the leading organisation for skin cancer professionals in New Zealand.
We are working towards a future with fewer skin cancers, and where every person - no matter who they are or where they live - receives the best possible care.
By shaping strategy, defining best practice, supporting professionals and advocating for change, we are driving a nationwide effort to improve outcomes and strengthen how skin cancers are prevented, detected and treated across New Zealand.
Join the Skin Cancer NZ Foundation Club
A unique opportunity to be part of Skin Cancer NZ’s journey from the beginning. With only 100 places available, a one-off contribution will secure your spot as a founding member and help build a strong foundation for long-term impact.
Become a member
Skin Cancer NZ brings together health professionals, health promoters, researchers, policy makers, and advocates who are committed to improving skin cancer prevention, early detection and care.
Membership is free and takes less than a minute to complete.
Latest news
28 May 2026
Experts highlight that while melanoma detection has improved, widespread screening is also leading to significant overdiagnosis and strain on healthcare systems, prompting a shift toward targeted, risk-based screening, improved diagnostic classification, and careful use of new technologies like AI to better balance benefits and harms.20 May 2026
Only some melanoma patients respond to anti–PD-1 immunotherapy, and there is currently no reliable way to predict this in advance. This study identifies DNA methylation and gene expression patterns in tumours that are linked to treatment response and may help guide more personalised treatment in the future.20 May 2026
Immune checkpoint inhibitors have improved outcomes for melanoma, but many patients still do not respond. This review outlines key reasons for treatment resistance and highlights growing evidence that the gut microbiota may influence immunotherapy response. It also considers the potential of microbiota-based approaches to help predict or improve outcomes.With thanks to our Founding Members
Supporting a future with better skin cancer outcomes for all New Zealanders.
Already a member?
Log in to update your details and access member content. Contact us if you need help.